financetom
Business
financetom
/
Business
/
Maersk shares hit three-month low on prospect of Gaza deal reopening Red Sea route
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Maersk shares hit three-month low on prospect of Gaza deal reopening Red Sea route
Oct 9, 2025 3:55 AM

COPENHAGEN (Reuters) -Maersk shares fell on Thursday on expectations a Gaza ceasefire deal could eventually restore container shipping routes through the Red Sea and Suez Canal, easing a capacity crunch that has supported freight rates.

Israel and Hamas agreed on Wednesday to the first phase of U.S. President Donald Trump's plan for Gaza, raising hopes Yemen's Iran-aligned Houthi forces might halt attacks on commercial shipping in the Red Sea. Such attacks have forced shippers to reroute south of Africa since late 2023.

However, the Houthis have yet to comment on the ceasefire deal or signal any policy change. The group claimed responsibility for attacking a Dutch-operated vessel last week.

Shares in the Danish shipping company were down 2% at 1025 GMT, touching their lowest since July 8.

"Maersk is falling due to the expectation of further drops in the freight rates in connection with a higher probability of safe passage through the Red Sea," Sydbank analyst Mikkel Emil Jensen said.

Analysts warned that even if the ceasefire holds, shipping companies were likely to wait months for assurances that attacks will not resume.

A Maersk spokesperson reiterated the group will consider resuming transit through the Red Sea only once a long-term and viable security solution had been established.

"There is a clear link between the security risks in the Bab al-Mandab Strait and the conflict in Gaza, though it remains too early to assess how progress in Gaza will influence the situation in the Red Sea," it said.

"We hope this agreement marks the first step toward ending the conflict and achieving lasting peace."

A return to Suez would increase available shipping capacity and put further pressure on freight rates, which have already declined from peaks earlier this year, according to analysts at Sydbank and ABG Sundal Collier.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BRIEF-Mubadala Capital To Take CI Financial Private Via Premium, All-Cash Offer
BRIEF-Mubadala Capital To Take CI Financial Private Via Premium, All-Cash Offer
Nov 25, 2024
Nov 25 (Reuters) - CI Financial Corp ( CIXXF ): * MUBADALA CAPITAL TO TAKE CI FINANCIAL PRIVATE VIA PREMIUM, ALL-CASH OFFER * CI FINANCIAL CORP ( CIXXF ) - SHAREHOLDERS TO RECEIVE $32.00 PER SHARE IN CASH * CI FINANCIAL CORP ( CIXXF ) - OFFER VALUES CI'S EQUITY AT $4.7 BILLION * CI FINANCIAL CORP ( CIXXF )...
Bath & Body Works Raises Full-Year Earnings Outlook Following Fiscal Third-Quarter Beat
Bath & Body Works Raises Full-Year Earnings Outlook Following Fiscal Third-Quarter Beat
Nov 25, 2024
09:12 AM EST, 11/25/2024 (MT Newswires) -- Bath & Body Works ( BBWI ) shares jumped early Monday after the company lifted its full-year earnings outlook as it recorded better-than-expected fiscal third-quarter results. The personal care and home fragrance retailer now anticipates adjusted earnings to be in a range of $3.15 to $3.28 per share for fiscal 2024, up from...
EU says Bluesky is violating information disclosure rules
EU says Bluesky is violating information disclosure rules
Nov 25, 2024
BRUSSELS (Reuters) - Bluesky, the rapidly growing social media platform, is violating EU regulations by failing to disclose important details, a European Commission spokesperson told reporters during a daily briefing on Monday. All platforms in the EU even the smallest ones which are below the threshold, which is the case for Bluesky,  have to have a dedicated page on their website...
BRIEF-Eton Pharmaceuticals Announces Acquisition Of U.S. Rights To Amglidia
BRIEF-Eton Pharmaceuticals Announces Acquisition Of U.S. Rights To Amglidia
Nov 25, 2024
Nov 25 (Reuters) - Eton Pharmaceuticals Inc ( ETON ): * ETON PHARMACEUTICALS ANNOUNCES ACQUISITION OF U.S. RIGHTS TO AMGLIDIA (GLYBURIDE ORAL SUSPENSION) * ETON PHARMACEUTICALS INC ( ETON ) - PLANS FDA MEETING IN Q1 2025, NDA SUBMISSION IN 2026 Source text: Further company coverage: ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved